Literature DB >> 20014979

Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS.

A R Salter1, G R Cutter, T Tyry, R A Marrie, T Vollmer.   

Abstract

OBJECTIVE: To assess the effects of mobility loss on instrumental activities of daily living (IADL) and socioeconomic status in multiple sclerosis (MS) patients.
METHODS: Participants were active registrants in the North American Research Committee on Multiple Sclerosis registry completing the Fall 2006 (IADL analysis, n = 10,396) or Spring 2007 (socioeconomic analysis, n = 8180) surveys. Cross-sectional correlations and linear and logistic regression were performed using sociodemographic factors, mobility scales, and Patient Determined Disease Steps as independent variables and IADLs as the response.
RESULTS: Mobility loss was significantly correlated with decreased IADL scores (r = -0.74; p < 0.0001); this correlation remained significant after adjustment for covariates. Mobility loss also negatively correlated with employment (r = -0.48 for women; r = -0.50 for men, both p < 0.0001) and annual income (r = -0.29; p < 0.0001). These correlations were all significant even with mild mobility loss. The relationships derived from the regression models suggest that the effect of mobility on employment is greater than the effect of demographic variables, and a small but direct effect on annual income that is independent of effects mediated through employment. The self-reported diagnosis of MS for study inclusion and use of single-item ordinal scales for mobility and disability can potentially be criticized as study limitations, although the diagnosis and the scales were previously validated.
CONCLUSION: Mobility loss independently correlated with IADL, and associated with reduced socioeconomic status in people with MS. These correlations were significant with mild mobility loss, supporting early treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20014979     DOI: 10.1185/03007990903500649

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  20 in total

1.  Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS.

Authors:  Bianca Weinstock-Guttman; Steven L Galetta; Gavin Giovannoni; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Paul W O'Connor; J Theodore Phillips; Chris Polman; William H Stuart; Frances Lynn; Christophe Hotermans
Journal:  J Neurol       Date:  2011-10-19       Impact factor: 4.849

2.  Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world.

Authors:  Myla D Goldman; Robert W Motl; John Scagnelli; John H Pula; Jacob J Sosnoff; Diego Cadavid
Journal:  Neurology       Date:  2013-10-30       Impact factor: 9.910

3.  The MoSt Project--more steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.

Authors:  Ruggero Capra; Mario Alberto Battaglia; Antonio Gaudioso; Laura Lopes; Damiano Paolicelli; Marco Paoloni; Carlo Pozzilli; Valter Santilli; Claudio Solaro; Maria Trojano
Journal:  J Neurol       Date:  2014-01-22       Impact factor: 4.849

4.  Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners.

Authors:  Nicholas G Larocca
Journal:  Patient       Date:  2011       Impact factor: 3.883

5.  The development of ICF Core Sets for multiple sclerosis: results of the International Consensus Conference.

Authors:  Michaela Coenen; Alarcos Cieza; Jenny Freeman; Fary Khan; Deborah Miller; Andrea Weise; Jürg Kesselring
Journal:  J Neurol       Date:  2011-03-04       Impact factor: 4.849

6.  Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.

Authors:  Myla D Goldman; Melanie D Ward; Robert W Motl; David E Jones; John H Pula; Diego Cadavid
Journal:  Mult Scler       Date:  2016-12-07       Impact factor: 6.312

7.  Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.

Authors:  Cecilie Fjeldstad; Gustavo Suárez; Michael Klingler; Herbert R Henney; Adrian L Rabinowicz; Gabriel Pardo
Journal:  Int J MS Care       Date:  2015 Nov-Dec

8.  The impact of slower walking speed on activities of daily living in patients with multiple sclerosis.

Authors:  M Yildiz
Journal:  Int J Clin Pract       Date:  2012-11       Impact factor: 2.503

9.  Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis.

Authors:  Craig I Coleman; Matthew F Sidovar; Matthew S Roberts; Christine Kohn
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Social and economic burden of walking and mobility problems in multiple sclerosis.

Authors:  James Pike; Edward Jones; Krithika Rajagopalan; James Piercy; Peter Anderson
Journal:  BMC Neurol       Date:  2012-09-18       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.